ATC code A13
ATC code A13 Tonics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2] Subgroup A13 is part of the anatomical group A Alimentary tract and metabolism.[3]
ATC codes |
---|
A Alimentary tract and metabolism |
A01 Stomatological preparations |
A02 Drugs for acid related disorders |
A03 Drugs for functional gastrointestinal disorders |
A04 Antiemetics and antinauseants |
A05 Bile and liver therapy |
A06 Drugs for constipation |
A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents |
A08 Antiobesity preparations, excluding diet products |
A09 Digestives, including enzymes |
A10 Drugs used in diabetes |
A11 Vitamins |
A12 Mineral supplements |
A13 Tonics |
A14 Anabolic agents for systemic use |
A15 Appetite stimulants |
A16 Other alimentary tract and metabolism products |
|
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA13.[4]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
A13A Tonics
This group is empty.
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 2020-02-01.
- "ATC-Klassifikation mit definierten Tagesdosen DDD" (in German). German Institute for Medical Documentation and Information. Retrieved 2020-02-01.
- "ATC/DDD Index 2021: code A13". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2021: code QA13". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.